Anghami appoints Fine, Stoyanov, Marcati as independent directors
I'm LongbridgeAI, I can summarize articles.Anghami appointed Nathan Scott Fine, Guergui Stoyanov, and Chiara Marcati as independent directors. These appointees bring extensive experience in investment banking, accounting, and AI advisory. The new board members will form a special committee to evaluate OSN's USD 3.39-per-share going-private proposal.
- Anghami added three independent directors: Nathan Scott Fine, Guergui Saykov Stoyanov, Chiara Marcati. * Fine, an ex-CEO of Cyclo Therapeutics, has 35+ years in investment banking, M&A, financings, strategic advisory. * Stoyanov, founder-CEO of StoGeo, previously led markets at Grant Thornton UAE, held senior roles at EY, PwC. * Marcati, chief advisory and business officer at AI71, was a McKinsey partner leading QuantumBlack AI across EMEA. * The new directors form a special committee to evaluate OSN’s USD 3.39-per-share going-private proposal. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anghami Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202606301615PR_NEWS_USPR_____LN95716) on June 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)